[ad_1]
Seven people who received the dose of AstraZeneca against COVID-19 died of blood clots in the UK, out of a total of 30 cases identified so far, noted the British Medicines Agency (MHRA).
For now more than 18 million doses have been administered, the agency pointed out.
“Of the 30 registered cases, including March 24, unfortunately seven died,” said the MHRA.
The entity pointed out that received information on 22 cases of cerebral vein thrombosis and 8 other cases of thrombosis associated with a deficiency of platelets.
Other coronavirus vaccines are not related to thrombi
The MHRA noted that it continues “Carefully examining these cases” and specified that no A similar case has been reported for the Pfizer / BioNTech vaccine.
However, the report points out that “The advantages of the AstraZeneza vaccine to prevent infection of the coronavirus and its complications clearly outweigh the risks, and the public must continue to receive the vaccine. “
On Thursday, the MHRA had indicated in a report on side effects of vaccines administered in that country that “The risk of having this type of blood clot is very low.”
The AstraZeneca vaccine, developed with the University of Oxford, is under surveillance in several countries after severe cases of thrombosis. In fact, In the Netherlands, the AstraZeneca vaccine was suspended in people under 60 years of age, due to the death of a woman.
